Oramed Pharmaceuticals (ORMP) Free Cash Flow (2010 - 2026)
Oramed Pharmaceuticals (ORMP) posted Free Cash Flow of -$2.9 million for Q1 2026, down 523.93% on a QoQ basis from -$468000.0 in Q4 2025, and up 17.09% year-over-year from -$2.5 million in Q1 2025.
Oramed Pharmaceuticals (ORMP) Free Cash Flow (2010 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$2.9 million for Q1 2026.
- Quarterly Free Cash Flow rose 17.09% year-over-year to -$2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.6 million (up 18.35% YoY) and the FY2025 annual result came in at -$9.2 million, down 8.59% from the prior year.
- Free Cash Flow was -$2.9 million for Q1 2026 at Oramed Pharmaceuticals, down from -$468000.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $2.1 million in Q2 2024 and bottomed at -$9.2 million in Q1 2022.
- A 5-year average of -$3.5 million and a median of -$2.7 million in 2023 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 178.22% in 2024, while the deepest fall reached 878.79% in 2024.
- Oramed Pharmaceuticals' Free Cash Flow stood at -$8.4 million in 2022, then jumped by 83.02% to -$1.4 million in 2023, then sank by 35.26% to -$1.9 million in 2024, then surged by 75.65% to -$468000.0 in 2025, then slumped by 523.93% to -$2.9 million in 2026.
- Business Quant data shows ORMP's Free Cash Flow at -$2.9 million in Q1 2026, -$468000.0 in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | -2.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.92 Mn |
| Mar 31, 2026 | -2.92 Mn |
| Dec 31, 2025 | -468,000.00 |
| Dec 31, 2025 | -468,000.00 |
| Sep 30, 2025 | -1.63 Mn |
| Sep 30, 2025 | -1.63 Mn |
| Jun 30, 2025 | -3.54 Mn |
| Jun 30, 2025 | -3.54 Mn |
| Mar 31, 2025 | -3.52 Mn |
| Mar 31, 2025 | -3.52 Mn |
| Dec 31, 2024 | -1.92 Mn |
| Dec 31, 2024 | -1.92 Mn |
| Sep 30, 2024 | -7.11 Mn |
| Sep 30, 2024 | -7.11 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | -1.48 Mn |
| Mar 31, 2024 | -1.48 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Dec 31, 2023 | -1.42 Mn |